Previous studies in mesothelioma and ovarian cancer revealed that Merlin expression may be associated with sensitivity to FAK inhibitors and that low Merlin/high FAK co-correlate with poor patient survival in pancreatic cancer [5,37,38,42,76]. This evidence concerns the gene PTK2 and familial pancreatic carcinoma.